Accessibility Statement

Last Updated: 2022-02-25 15:34:00

Kramer Laboratories, Inc. is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards. Nizoral.com will be tested on a periodic basis with assistive technology such as screen readers and screen magnifiers, and with users with disabilities who use these technologies.

Conformance Status

The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. Nizoral.com is partially conformant with WCAG 2.0 level AA. Partially conformant means that some parts of the content do not fully conform to the accessibility standard.
Some examples of partially conformant content:

  • Digital and/or digitized documents originally intended for print
  • 3rd party logos and branding with restrictive brand guidelines
  • 3rd party embedded content such as videos, iframes or forms

If you need assistance with partially conformant content please contact [email protected]

Feedback

Please be aware that our efforts are ongoing. We appreciate your feedback, please let us know if you encounter accessibility barriers. You can submit your accessibility concerns via the following channels:

We try to respond to feedback within 2 business days.

Technical Specifications

Accessibility of Nizoral.com relies on the following technologies to work with the particular combination of web browser and any assistive technologies or plugins installed on your computer:

  • HTML
  • CSS
  • JavaScript

These technologies are relied upon for conformance with the accessibility standards used.

Assessment Approach

Kramer Laboratories, Inc. assessed the accessibility of Nizoral.com by the following approaches:

  • Self-evaluation